Autonomix Medical Stock Scheduled to Reverse Split on Wednesday, June 24th (NASDAQ:AMIX)

Autonomix Medical, Inc. (NASDAQ:AMIX)’s stock is set to reverse split on Wednesday, June 24th. The 1-21 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Tuesday, June 23rd.

Autonomix Medical Stock Performance

Shares of AMIX stock opened at $0.37 on Friday. Autonomix Medical has a 52-week low of $0.20 and a 52-week high of $2.64. The company has a market capitalization of $2.56 million, a PE ratio of -0.10 and a beta of -1.43. The business’s fifty day moving average is $0.38 and its 200 day moving average is $0.46.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the company. Zacks Research upgraded Autonomix Medical to a “hold” rating in a research report on Tuesday, June 2nd. Weiss Ratings cut Autonomix Medical from a “sell (e+)” rating to a “sell (e)” rating in a report on Wednesday, June 3rd. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $2.00.

About Autonomix Medical

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.